Previous 10 | Next 10 |
2023-11-07 09:58:32 ET DENVER, Colo., Nov. 7, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; PaxMedica Inc (NASDAQ: PXMD), Olaplex Holdings Inc (NASDAQ: OLPX), Hims & Hers Health Inc (NYSE: HIMS), Th...
2023-11-07 09:36:16 ET DENVER, Colo., Nov 7, 2023 ( www.247marketnews.com )- Senti Biosciences Inc. (NASDAQ: SNTI) stated, after yesterday’s market close, that it entered a new strategic collaboration with Celest Therapeutics, a China-based biotechnology company, for the clinical...
2023-11-06 17:21:40 ET More on Senti Biosciences Seeking Alpha’s Quant Rating on Senti Biosciences Historical earnings data for Senti Biosciences Financial information for Senti Biosciences For further details see: Senti stock soars 175% on Chinese...
– Celest to lead clinical development with technical support from Senti Bio – – First patient expected to be enrolled in China in 1H 2024 – – Senti Bio eligible to receive up to $156 million in milestones and royalties – SOUTH SAN ...
– Two poster presentations highlighting new preclinical data with BlueRock Therapeutics – – Two poster presentations showcasing Senti Bio’s proprietary Gene Circuit platform – SOUTH SAN FRANCISCO, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Senti B...
- Four abstracts highlight Gene Circuit platforms that enhance the scope, precision, effectiveness, and controllability of oncology cell therapies - - Abstracts include new preclinical data demonstrating ongoing progress from collaboration with BlueRock Therapeutics and new technology d...
SOUTH SAN FRANCISCO, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a biotechnology company developing a new generation of cell and gene therapies for patients living with incurable diseases using its proprietary Gene Circuit platfor...
2023-08-11 10:41:32 ET Senti Biosciences press release ( NASDAQ: SNTI ): Q2 GAAP EPS of -$0.42. Revenue of $0.93M (-31.1% Y/Y). For further details see: Senti Biosciences GAAP EPS of -$0.42, revenue of $0.93M
– GeneFab transaction provides access to clinical manufacturing and extends cash runway into Q4 2024 – – IND for SENTI-202, potentially the first Logic Gated CAR-NK treatment for AML, on track for 2H 2023 – – Cash, cash equivalents, and sho...
– Celadon Partners to acquire Senti’s manufacturing facility and CMC capabilities to establish GeneFab, an independent manufacturing business for cell and gene therapies – – Transaction anticipated to extend Senti Bio’s cash runway into Q4 2024 –...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
5.74%Change Percent:
Senti Biosciences Inc. Company Name:
SNTI Stock Symbol:
NASDAQ Market:
Senti Biosciences Inc. Website:
A look at the top 10 most actives in the United States Zoomcar Holdings Inc. (ZCAR) rose 58.3% to $0.2162 on volume of 130,087,791 shares Maxeon Solar Technologies Ltd. (MAXN) rose 3.6% to $0.1863 on volume of 71,767,970 shares SMX (Security Matters) Public Limited Company (SMX) rose 17.1...
A look at the top 10 most actives in the United States Senti Biosciences Inc. (SNTI) rose 51.3% to $0.4175 on volume of 386,768,896 shares NVIDIA Corporation (NVDA) rose 0.6% to $124.3 on volume of 277,459,318 shares PROSHARES TRUST (SQQQ) fell 1.9% to $8.12 on volume of 139,088,335 share...
A look at the top 10 most actives in the United States Complete Solaria Inc Com (CSLR) rose 58.5% to $1.775 on volume of 71,457,263 shares Senti Biosciences Inc. (SNTI) rose 55.1% to $0.428 on volume of 64,207,396 shares Golden Heaven Group Holdings Ltd. (GDHG) rose 13.3% to $0.1711 on vo...